The third type of inflammation (free-radical damage) is best reduced by the transcription factor Nrf-2, which is activated by polyphenols (12)
By including all English-language studies on muscle mass loss during GLP-1RA therapy in T2D and obesity from major scientific databases and clinical trial registries, this narrative review synthesizes the current knowledge on the epidemiology and mechanisms of muscle loss in diabetes and obesity, with a focus on the impact of GLP-1RAs therapy
Tirzepatide is the active ingredient in Mounjaro and Zepbound, FDA-approved for type 2 diabetes and chronic weight management
Consult your physician about dose adjustments or medication changes
These include: Anaphylaxis (severe allergic reaction): Symptoms may include swelling of the face, lips, tongue or throat, difficulty breathing, wheezing, dizziness or feeling faint
It should be noted that the rate of WL with the novel pharmacotherapies could be individualised, something that is not feasible with bariatric surgery, however the optimal WL rate to optimise the risks for nutritional complications and/or cholelithiasis will need further research [107]